Will HIV Make a Comeback as Progress is Threatened?

Remarkable progress in HIV science has brought us a groundbreaking long-acting injectable drug offering six months of protection, a potential game-changer in the fight against the epidemic. However, decades of hard-won gains are under threat as political and social challenges loom, reports the International Aids Society.

Millions of people are at risk of losing access to life-saving treatment due to the suspension of aid funding by the United States. In addition, regressive policies and human rights abuses, such as Uganda's anti-gay laws are fueling the epidemic in regions with the highest HIV burdens.

These setbacks threaten the UNAIDS 95-95-95 targets, which aim to ensure that by 2030, 95% of people living with HIV know their status, receive treatment, and achieve viral suppression. In light of funding cuts, clinic closures, and rising stigma, will HIV make a devastating comeback, reversing years of progress and putting millions of lives at risk?

InFocus

A woman in Kampala, Uganda, holds her HIV treatment drugs in May 2022. Hundreds of thousands of Ugandans living with HIV are not on antiretroviral medication, and concerns are growing that a US executive order could affect access to HIV prevention and treatment, largely funded by PEPFAR.

AllAfrica publishes around 500 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.